Advertisement
Browse Subject Areas
?

Click through the PLOS taxonomy to find articles in your field.

For more information about PLOS Subject Areas, click here.

  • Loading metrics

Open Access

Correction

Correction: The Nerve Growth Factor Receptor CD271 Is Crucial to Maintain Tumorigenicity and Stem-Like Properties of Melanoma Cells

  • The PLOS ONE Staff
  • Article
  • Metrics
  • Comments
  • Media Coverage

There are errors in some of the authors' affiliations listed for this article. Please refer to the correct affiliations below:

Torben Redmer, Yvonne Welte, Dorothea Przybilla, Wasco Wruck, Reinhold Schäfer, Christian R. A. Regenbrecht

  1. 1 Institute for Pathology, Charité - Universitätsmedizin Berlin, Berlin, Germany

Diana Behrens, Iduna Fichtner

  1. 2 Experimental Pharmacology & Oncology Berlin-Buch GmbH, Berlin, Germany

Wasco Wruck, Christian R. A. Regenbrecht

  1. 3 Laboratory of Functional Genomics (LFGC), Charité - Universitätsmedizin Berlin, Berlin, Germany

Marie-Laure Yaspo, Hans Lehrach

  1. 4 Max-Planck Institute for Molecular Genetics, Berlin, Germany

Dorothea Przybilla, Reinhold Schäfer, Christian R. A. Regenbrecht

  1. 5 Comprehensive Cancer Center Charité, Charité - Universitätsmedizin Berlin, Berlin, Germany

Reference

  1. 1. Redmer T, Welte Y, Behrens D, Fichtner I, Przybilla D, et al. (2014) The Nerve Growth Factor Receptor CD271 Is Crucial to Maintain Tumorigenicity and Stem-Like Properties of Melanoma Cells. PLoS ONE 9(5): e92596

Citation: The PLOS ONE Staff (2014) Correction: The Nerve Growth Factor Receptor CD271 Is Crucial to Maintain Tumorigenicity and Stem-Like Properties of Melanoma Cells. PLoS ONE 9(8): e105274. https://doi.org/10.1371/journal.pone.0105274

Published: August 4, 2014

Copyright: © 2014 The PLOS ONE Staff. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.